November 18, 2026
Health news, explained with evidence
LIVE

AI and Radiomics May Support Lung Cancer Care, Review Finds

🧠 AI Analysis 1 min read 👁 3

Combining radiomics with multimodal artificial intelligence shows promise as a decision-support tool for lung cancer, though researchers caution that real-world implementation requires further validation.

🧠AI Analysis

Key points

  • Review evaluates radiomics and multimodal AI for lung cancer diagnosis, staging, and treatment planning.
  • Existing research is primarily retrospective and focused on non-small cell lung cancer.
  • Clinical adoption depends on reproducible workflows, independent validation, and proven utility.

A narrative review led by researchers at the Sichuan Cancer Hospital & Institute indicates that combining radiomics with multimodal artificial intelligence may help clinicians diagnose, stage, and evaluate treatment response in lung cancer. The findings suggest that these digital health tools could serve as complementary decision-support systems to assist medical teams throughout patient care.

The review authors—including Shuo Zhang, Dan Zhang, Jinting Zhou, and Qiong Liu—noted that current scientific evidence remains largely retrospective and heavily concentrated on non-small cell lung cancer. To transition these tools into routine practice, the research team emphasized that systems must demonstrate reproducible workflows, independent validation, precise calibration, and verified clinical utility.

What to know: Radiomics involves extracting detailed quantitative data from medical images to identify subtle disease features. While multimodal AI models show potential in enhancing diagnostic accuracy, experts stress that these platforms are designed to support, rather than replace, professional medical evaluation. Patients with questions about lung cancer screening or treatment management should discuss their options directly with their doctor.

Source Nature Health Sciences — nature.com/articles/s41746-026-03508-2 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.